A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady State
Phase 1
Completed
- Conditions
- Healthy SubjectsBioavailabilityPharmacokinetics
- Interventions
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01121926
Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01121913
A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily)
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT01121900
A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Zaldiar®Drug: Ultracet®, multiple doses, (fed & fasting)
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2012-04-25
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT00973232
- Locations
- 🇬🇧
Guy's Drug Research Unit, Quintiles Ltd, London, United Kingdom
A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day
- First Posted Date
- 2009-08-04
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT00952068
A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol HCl / Contramid® Tablets to Twice Daily Tramadol HCl (SR) for the Treatment of Osteoarthritis of the Knee
Phase 3
Completed
- Conditions
- Osteoarthritis, KneePain
- Interventions
- First Posted Date
- 2009-08-03
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 431
- Registration Number
- NCT00950651
A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol OAD Tablets to Twice Daily Tramadol BID for the Treatment of Osteoarthritis of the Knee (Extension Protocol) and Open Label Safety Follow-Up
Phase 3
Completed
- Conditions
- PainOsteoarthritis, Knee
- Interventions
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 238
- Registration Number
- NCT00912015
Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg
- First Posted Date
- 2009-06-02
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00911742
A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee (With 7-Day Follow-up)
- First Posted Date
- 2009-02-27
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 552
- Registration Number
- NCT00852917
Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers
- First Posted Date
- 2009-02-09
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00839072
- Locations
- 🇨🇦
Algorithme Pharma Inc., Laval, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath